Daniel D. Shoemaker
2015
In 2015, Daniel D. Shoemaker earned a total compensation of $956.8K as Chief Scientific Officer at Fate Therapeutics, a 26% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $50,563 |
---|---|
Option Awards | $238,714 |
Salary | $317,555 |
Stock Awards | $349,965 |
Total | $956,797 |
Shoemaker received $350K in stock awards, accounting for 37% of the total pay in 2015.
Shoemaker also received $50.6K in non-equity incentive plan, $238.7K in option awards and $317.6K in salary.
Rankings
In 2015, Daniel D. Shoemaker's compensation ranked 8,180th out of 13,638 executives tracked by ExecPay. In other words, Shoemaker earned more than 40.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,180 | 40th |
Manufacturing | 3,122 | 40th |
Chemicals And Allied Products | 1,135 | 39th |
Drugs | 914 | 40th |
Biological Products, Except Diagnostic Substances | 157 | 38th |
Shoemaker's colleagues
We found three more compensation records of executives who worked with Daniel D. Shoemaker at Fate Therapeutics in 2015.